544184
Borosil Scientific Ltd
BSELast Traded Price
₹108.05
-1.65 (-1.50%)
Open
₹111.15
High
₹111.15
Low
₹105.85
Prev Close
₹109.70
Industry
Capital Goods
Market Cap
961.12 Cr
Filing History
Recent corporate announcements and filings for 544184
Routine
Neutral
2026-09-28 18:11
- Trading window closed for all Designated Persons and their immediate relatives effective October 01, 2026.
- Closure remains in effect until 48 hours after declaration of financial results for quarter and half year ending September 30, 2026.
- Board meeting date for approving results will be intimated separately.
Governance
Neutral
2026-09-25 19:51
- Borosil Scientific Limited held its 35th Annual General Meeting (AGM) on September 25, 2026.
- All 9 resolutions, including adoption of financial statements, re-appointment of directors and CEO, material related party transactions, fundraising, and ESOP amendments, were passed with the requisite majority.
- Voting results and the consolidated scrutinizer's report have been successfully submitted pursuant to Regulation 44 of SEBI LODR Regulations.
Governance
Neutral
2026-09-25 17:27
- Borosil Scientific Limited held its 35th Annual General Meeting (AGM) on September 25, 2026, through video conferencing.
- Shareholders considered and discussed the adoption of audited standalone and consolidated financial statements for FY 2025-26.
- Proposals included the re-appointment of Mr. Pradeep Kumar Kheruka and Mr. Vinayak Madhukar Patankar, approval of related party transactions, fundraising, and amendments to ESOP schemes.
Governance
Negative
2026-09-23 19:02
CRITICAL RED FLAG DETECTED
- Mr. Kailash Motwani, Head - Operations (Senior Management Personnel) of a material subsidiary, has resigned from Borosil Scientific Limited. His resignation is effective September 23, 2026, due to personal reasons.
Business Update
Positive
2026-09-22 13:35
- Borosil Scientific Limited's Board approved the expansion of production capacity by setting up an additional manufacturing facility in Bharuch, Gujarat, on September 22, 2026.
- Capacity will expand from ~15 lakh units to ~108 lakh units per annum.
- Commercial production is expected to begin by March 2027.
- Estimated capital expenditure is ₹60 crores, to be financed through internal accruals and/or borrowings.
- The expansion is driven by strong and growing demand for glassware products from Borosil Limited (BL).
Business Update
Positive
2026-09-22 13:26
- Board approved expansion of glassware production capacity from ~15 lakh to ~108 lakh units per annum at Bharuch. - Estimated CAPEX of ₹60 Cr, with commercial production expected by March 2027. - Driven by strong and growing demand, and increased sourcing from Borosil Limited.
Ownership
Neutral
2026-08-13 19:40
- Borosil Scientific Limited allotted 4,475 equity shares on August 13, 2026, upon exercise of vested stock options under its ESOP scheme at an exercise price of ₹141 per share. These shares rank pari-passu with existing equity shares. The total issued and paid-up equity share capital now stands at 8,89,51,525 equity shares of Re. 1/- each.
Financials
Positive
2026-08-03 17:59
- Consolidated Revenue ₹106.75Cr vs ₹95.98Cr (▲11.23% YoY)
- EBITDA ₹10.87Cr vs ₹7.41Cr (▲46.72% YoY)
- PAT ₹4.36Cr vs ₹(4.21)Cr (Turned profitable from a loss YoY)
- EBITDA Margin 10.18% vs 7.72% (▲246bps)
Financials
Positive
2026-08-03 17:51
- Consolidated Revenue ₹10,675.23 Lakhs vs ₹9,597.64 Lakhs (▲11.23% YoY)
- EBITDA ₹1,112.27 Lakhs vs ₹779.10 Lakhs (▲42.76% YoY)
- PAT attributable to owners ₹437.08 Lakhs for Q1 FY27 compared to a loss of ₹(416.43) Lakhs in Q1 FY26 (YoY turnaround from loss to profit)
- EBITDA Margin 10.42% vs 8.12% (▲230bps)
- The Board also approved modifications to ESOP schemes, increasing the maximum discount limit for new options from 10% to 20%.
Governance
Neutral
2026-07-27 18:09
- Board meeting on August 3, 2026, to approve Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026.
- Trading window for designated persons remains closed until 48 hours after results declaration.
Routine
Neutral
2026-07-14 22:22
New Filing detected. See link for details.
Routine
Neutral
2026-06-30 15:25
- Borosil Scientific Limited responded to BSE's query regarding an increase in its security's price/volume.
- The company confirmed it has not withheld any material information/event that requires disclosure under SEBI regulations.
- The increase in price/volume is attributed to market-driven factors.
Routine
Neutral
2026-06-25 18:32
- Intimation of Closure of Trading Window for Borosil Scientific Limited.
- Trading window to remain closed for Designated Persons and their immediate relatives from July 01, 2026.
- Closure is for the declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ending June 30, 2026.
- The window will reopen 48 hours after the declaration of results.
Governance
Positive
2026-05-22 11:32
Borosil Scientific Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms the company's full compliance with all applicable SEBI Regulations, including LODR, ICDR, SAST, and Insider Trading Regulations, and Secretarial Standards. It highlights no disqualification of directors, no resignation of statutory auditors, and no regulatory actions by SEBI or Stock Exchanges during the review period.
Ownership
Positive
2026-05-20 19:02
Borosil Scientific Limited's Nomination and Remuneration Committee approved the grant of 18,700 employee stock options on May 20, 2026. Each option, priced at ₹108 (approximately 10% discount to the market price), entitles the holder to one equity share of Re. 1/-. The options will vest 25% annually over four years from the grant date, with an exercise period of five years from vesting.